Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03274492 |
|---|---|
| Brief Title: | A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma (POLARIX) |
| First Submitted : | September 5, 2017 |
| First Submitted that Met QC Criteria : | September 5, 2017 |
| First Posted : | September 7, 2017 |
| Last Update Submitted that Met QC Criteria : | April 10, 2024 |
| Last Update Posted : | April 11, 2024 |